Moreover, as defects in mitoribosome biogenesis—resulting from, for example, mutations in MRM2 and GTPBP5—are increasingly implicated in mitochondrial disease11,39, the current work does not only describe fundamental cellular processes but may also further diagnostic and therapeutic approaches to mitochondrial diseases. This evidence concerns the gene MRM2 and mitochondrial disease.